Single-use Bioreactors Market Expected to Grow at a CAGR of 15.8% by 2031 - Persistence Market Research

Overview of the Single-use Bioreactors Market

The global single-use bioreactors (SUBs) market is set to experience robust growth, with a forecasted compound annual growth rate (CAGR) of 15.8%. Starting from a market value of US$3.8 billion in 2024, it is projected to reach US$10.8 billion by the end of 2031. This expansion reflects the increasing reliance on bioreactor technology within the pharmaceutical, biopharmaceutical, and biotechnology industries. The adoption of single-use systems is particularly notable for their versatility, cost-effectiveness, and operational efficiency in various production and research applications.

Key growth drivers behind this surge include the rising demand for biologics, the expansion of chronic and infectious diseases, and technological advancements in bioreactor design. The pharmaceutical and biopharma industries are at the forefront of this demand, as these sectors strive for faster production processes with reduced operational costs. The primary segment driving market growth includes biopharmaceutical companies, with North America leading the charge as the dominant region for single-use bioreactors due to its well-established pharmaceutical infrastructure and increasing chronic disease burden.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/33957

Key Highlights from the Report

• Market size: The global market for single-use bioreactors is valued at US$3.8 billion in 2024 and is expected to reach US$10.8 billion by 2031.
• Growth rate: The market is projected to grow at a CAGR of 15.8% from 2024 to 2031.
• Product segment: Single-use bioreactor systems, especially stirred-tank bioreactors, lead the market due to their efficiency in oxygen transfer and fluid mixing.
• End-user segment: Biopharmaceutical companies dominate the market, contributing significantly to demand for disposable bioreactors.
• Regional growth: North America holds the largest market share due to the prevalence of chronic diseases and a strong pharmaceutical development base.
• Innovation: New product developments, such as the 3,000 L and 5,000 L HyPerforma DynaDrive bioreactors, are fueling market growth by improving scalability and cost-efficiency.

Market Segmentation

Product Type Segmentation

Single-use bioreactors are categorized based on their design and functionality. The most common types include stirred-tank bioreactors, wave-mixed bioreactors, and airlift bioreactors. Stirred-tank bioreactors, particularly, dominate the market due to their ability to provide efficient oxygen transfer, effective fluid mixing, and ease of scalability. Their widespread use across a range of applications, from vaccine production to therapeutic protein development, contributes to their dominant market share.

End-User Segmentation

The market is primarily driven by the biopharmaceutical sector, which accounts for around 66% of the total market demand. Biopharmaceutical companies are increasingly adopting single-use bioreactors to reduce capital investment costs, accelerate product development, and enhance production efficiency. This adoption is particularly evident in contract manufacturing organizations (CMOs) and contract research organizations (CROs) that require flexible, scalable, and cost-effective solutions for drug development and manufacturing.

Regional Insights

North America: The Dominant Region

North America, particularly the United States, is poised to remain the largest market for single-use bioreactors. The region's robust healthcare infrastructure, coupled with a high prevalence of chronic diseases like cardiovascular disorders and diabetes, drives the demand for biopharmaceutical products. Furthermore, North America's significant concentration of pharmaceutical manufacturing facilities and research institutions makes it a hub for innovation and adoption of single-use bioreactor systems.

Asia Pacific: The Fastest Growing Region

In contrast to North America, Asia Pacific is emerging as the fastest-growing region in the single-use bioreactor market. Countries such as China and India are rapidly scaling up their biopharmaceutical production capabilities due to the increasing demand for biologics and the rise of chronic diseases in the region. The expansion of biomanufacturing facilities in Asia is expected to fuel significant growth in the market for single-use bioreactors, driven by both local and international companies investing in advanced bioprocessing technologies.

Market Drivers

The single-use bioreactor market's growth is propelled by several factors. The increasing demand for biologics, such as monoclonal antibodies and vaccines, is a significant driver, as bioreactors are essential in their production. Additionally, the pharmaceutical industry's shift toward more cost-effective, scalable, and flexible manufacturing solutions has made single-use bioreactors increasingly attractive. The ability of these systems to reduce facility space, streamline production, and lower capital investments aligns well with the industry's needs for efficiency and speed.
Technological advancements in the design of single-use bioreactors, such as improved oxygen transfer, better fluid mixing, and more customizable capacities, further enhance their adoption. These developments allow for better scale-up capabilities, making single-use bioreactors ideal for both clinical trials and large-scale commercial production.

Market Restraints

Despite the numerous advantages, the single-use bioreactor market faces certain challenges. A key restraint is the concern over leachable and extractables, which are chemicals that can leach from the bioreactor bags into the drug substance. These chemicals, often used to enhance the performance of polymer materials, could potentially affect the quality of the final product. The lack of stringent regulatory standards on this matter continues to pose risks for manufacturers, hindering market growth.

Additionally, the environmental impact of waste disposal related to single-use bioreactors is a growing concern. The plastic waste generated from these disposable systems can be significant, and while decontamination methods such as incineration and landfilling are common, they are not sustainable. As the market for single-use bioreactors grows, the pressure to find environmentally friendly alternatives will intensify, presenting both a challenge and an opportunity for innovation.

Market Opportunities

The rise in chronic and infectious diseases worldwide presents a substantial opportunity for the single-use bioreactor market. Bioreactors have long been instrumental in the production of therapeutic agents for chronic diseases such as diabetes, cancer, and cardiovascular disorders. The global COVID-19 pandemic further demonstrated the critical role of single-use bioreactors in vaccine development and production. The rapid scaling of vaccine production highlighted the advantages of disposable bioreactors in fast-tracking therapeutic production during public health emergencies.

As the global healthcare burden continues to rise, especially in developing regions, the demand for cost-effective, scalable, and flexible production technologies will only grow. This presents significant opportunities for market players to capitalize on the increasing need for advanced biomanufacturing solutions.

Reasons to Buy the Report

✔ Comprehensive Market Insights: Gain an in-depth understanding of the single-use bioreactors market, including growth drivers, key trends, and future projections.
✔ Strategic Market Intelligence: Get detailed competitive intelligence, including key market players, their strategies, and innovations.
✔ Market Forecasts: Benefit from accurate market forecasts and growth rate predictions up to 2031.
✔ Regional Analysis: Understand market dynamics across key regions, including North America, Europe, and Asia Pacific.
✔ Informed Decision-Making: Make informed business decisions with detailed insights into market segmentation, drivers, restraints, and opportunities.

Frequently Asked Questions (FAQs)

1. How Big is the Single-Use Bioreactors Market?
2. Who are the Key Players in the Global Market for Single-Use Bioreactors?
3. What is the Projected Growth Rate of the Single-Use Bioreactors Market?
4. What is the Market Forecast for Single-Use Bioreactors by 2032?
5. Which Region is Estimated to Dominate the Single-Use Bioreactors Industry through the Forecast Period?

Company Insights

Key players in the single-use bioreactor market include:

• Applikon Biotechnology BV
• Cellexus Ltd.
• Celltainer Biotech B.V.
• Cesco Bioengineering Co. Ltd.
• Danaher Corporation
• ABEC, Inc.
• Distek, Inc.
• Eppendorf SE
• Thermo Fisher Scientific
• Pall Corporation
• Sartorius AG
• Merck KGaA
• GE Healthcare

Recent Developments:

1. Thermo Fisher Scientific launched the 3,000 L and 5,000 L HyPerforma DynaDrive single-use bioreactors in March 2021, enhancing scalability and cost-efficiency in bioprocessing.

2. ABEC, Inc. introduced a 6,000 L single-use bioreactor in September 2019, expanding the maximum production volume and improving the efficiency of cell culture per unit of floor space.

Conclusion

The single-use bioreactor market is on a strong upward trajectory, driven by increasing demand for biologics, chronic disease management, and technological innovations in bioprocessing. The ability of these systems to reduce costs, improve scalability, and enhance operational efficiency positions them as a preferred choice in both commercial and clinical production settings. Despite challenges related to waste disposal and material leachables, the future of the market looks promising, with significant growth potential across regions and industries.

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

This release was published on openPR.